| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,056 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,048,235 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
786,589 |
|
|
| Total
Value |
$64,987,085 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -34.0%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-04-12 |
474,994 |
2024-04-12 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
846 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 34
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGSX |
Neurogesx Inc |
Director |
– • – |
2007-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,999 |
|
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2015-01-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250 |
|
- |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2023-11-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,615 |
|
% |
|
| NGSX |
Neurogesx Inc |
See General Remarks |
– • – |
2007-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,822 |
13,821 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
8,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2009-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
45,440 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2009-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
50,440 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2009-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
59,440 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
86,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
94,067 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
99,067 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
123,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
131,093 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
132,093 |
0 |
- |
|
| ITMN |
InterMune Inc |
Director |
– • – |
2012-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,225 |
4,225 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
56,000 |
169,191 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
• • – |
2012-10-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
13,545 |
135,901 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
• • – |
2012-10-23 |
5 |
GA |
$0.00 |
$0 |
I/I |
13,545 |
13,545 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-05-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
111,838 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-05-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,064 |
20,609 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-05-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,064 |
90,101 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
37,800 |
125,901 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-05-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,131 |
115,770 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-05-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,131 |
40,740 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2013-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
706 |
706 |
0 |
- |
|
846 Records found
|
|
Page 1 of 34 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
